Table 2.
Prognostic factors affecting disease free survival and overall survival in univariate analysis.
Variables | Chi Square | 95% C.I. | P Value |
DFS | |||
1. Sex | 3.84 | 0.92 – 12.93 | 0.05* |
2. Tumor depth | 4.23 | 5.3 – 9.4 | <0.03* |
3. VRHD | 0.28 | 0.28 – 3.9 | 0.59 |
4. Tumour Necrosis | 0.56 | 0.2 – 10.4 | <0.76 |
5. Tumor mitosis | 0.027 | 0.22–3.53 | >0.86 |
6. Cellular differentiation | 11.95 | 2.01 – 111.75 | <0.002* |
7. Tumor grade | 1.69 | 0.14 – 1.51 | >0.19 |
8. Heterogeneous differentiation | 1.73 | 0.14 – 1.48 | 0.18 |
9. RT | 2.49 | 0.76 – 8.42 | 0.11 |
OS | |||
1. Sex | 4.02 | 0.94 – 13.27 | 0.04* |
2. Tumor depth | 1.86 | 0.4 – 1.18 | 0.17 |
3. VRHD | 0.15 | 0.18 – 4.08 | >0.37 |
4. Tumor Necrosis | 0.6 | 0.2–14.2 | >0.74 |
5. Tumor Mitosis | 0.012 | 0.2–4.8 | >0.98 |
6. Cellular differentiation | 15.50 | 2.44 – 334.28 | <0.0004* |
7. Tumor grade | 3.84 | 0.94 – 4.68 | 0.05* |
8. Heterogeneous differentiation | 0.89 | 0.15 – 1.95 | 0.34 |
9. RT | 2.66 | 0.10 – 1.28 | >0.10 |
10. Recurrence | 9.49 | 0.3 – 2.61 | <0.002* |
C.I. = Confidence Interval, DFS = Disease free survival, OS = Overall survival, VRHD = Von Reckling hausen's disease, RT = Radiotherapy, *: Statistically Significant.